These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19363136)

  • 1. Role of the MAPK/ERK pathway in valvular interstitial cell calcification.
    Gu X; Masters KS
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1748-57. PubMed ID: 19363136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cadherin-11 regulates cell-cell tension necessary for calcific nodule formation by valvular myofibroblasts.
    Hutcheson JD; Chen J; Sewell-Loftin MK; Ryzhova LM; Fisher CI; Su YR; Merryman WD
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):114-20. PubMed ID: 23162011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-activated protein kinase (MAPK) signalling pathways in HepG2 cells infected with a virulent strain of Klebsiella pneumoniae.
    Wu JH; Hong LC; Tsai YY; Chen HW; Chen WX; Wu TS
    Cell Microbiol; 2006 Sep; 8(9):1467-74. PubMed ID: 16922865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Rho pathway in regulating valvular interstitial cell phenotype and nodule formation.
    Gu X; Masters KS
    Am J Physiol Heart Circ Physiol; 2011 Feb; 300(2):H448-58. PubMed ID: 21131478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low frequency pulsed electromagnetic field promotes C2C12 myoblasts proliferation via activation of MAPK/ERK pathway.
    Xu H; Zhang J; Lei Y; Han Z; Rong D; Yu Q; Zhao M; Tian J
    Biochem Biophys Res Commun; 2016 Oct; 479(1):97-102. PubMed ID: 27629357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
    Lee SY; Shin SJ; Kim HS
    Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
    Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulation of valve composition to elucidate the role of collagen in aortic valve calcification.
    Rodriguez KJ; Piechura LM; Porras AM; Masters KS
    BMC Cardiovasc Disord; 2014 Mar; 14():29. PubMed ID: 24581344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group box-1 protein induces osteogenic phenotype changes in aortic valve interstitial cells.
    Wang B; Li F; Zhang C; Wei G; Liao P; Dong N
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):255-62. PubMed ID: 26515875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages survive hyperoxia via prolonged ERK activation due to phosphatase down-regulation.
    Nyunoya T; Monick MM; Powers LS; Yarovinsky TO; Hunninghake GW
    J Biol Chem; 2005 Jul; 280(28):26295-302. PubMed ID: 15901735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-α promotes and exacerbates calcification in heart valve myofibroblast populations.
    Gonzalez Rodriguez A; Schroeder ME; Grim JC; Walker CJ; Speckl KF; Weiss RM; Anseth KS
    FASEB J; 2021 Mar; 35(3):e21382. PubMed ID: 33554387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface chemistry regulates valvular interstitial cell differentiation in vitro.
    Rush MN; Coombs KE; Hedberg-Dirk EL
    Acta Biomater; 2015 Dec; 28():76-85. PubMed ID: 26428193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3',5'-cyclic adenosine monophosphate pathway.
    Le Péchon-Vallée C; Magalon K; Rasolonjanahary R; Enjalbert A; Gérard C
    Neuroendocrinology; 2000 Jul; 72(1):46-56. PubMed ID: 10940738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of ERK activation mediates the protection of necrostatin-1 on glutamate toxicity in HT-22 cells.
    Zhang M; Li J; Geng R; Ge W; Zhou Y; Zhang C; Cheng Y; Geng D
    Neurotox Res; 2013 Jul; 24(1):64-70. PubMed ID: 23307752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium Selenite Enhanced the Anti-proliferative Effect of MEK-ERK Inhibitor in Thyroid Cancer Cells.
    Kim JB; Yang EY; Woo J; Kwon H; Lim W; Moon BI
    In Vivo; 2020; 34(1):185-190. PubMed ID: 31882478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2.
    Cui M; Zhao Y; Hance KW; Shao A; Wood RJ; Fleet JC
    J Cell Physiol; 2009 Apr; 219(1):132-42. PubMed ID: 19097033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic induction of apoptosis in human leukemia cells (U937) exposed to bryostatin 1 and the proteasome inhibitor lactacystin involves dysregulation of the PKC/MAPK cascade.
    Vrana JA; Grant S
    Blood; 2001 Apr; 97(7):2105-14. PubMed ID: 11264178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer.
    Yeh JJ; Routh ED; Rubinas T; Peacock J; Martin TD; Shen XJ; Sandler RS; Kim HJ; Keku TO; Der CJ
    Mol Cancer Ther; 2009 Apr; 8(4):834-43. PubMed ID: 19372556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of ERK/MAPK in the lateral amygdala of the mouse is required for acquisition of a fear-potentiated startle response.
    Di Benedetto B; Kallnik M; Weisenhorn DM; Falls WA; Wurst W; Hölter SM
    Neuropsychopharmacology; 2009 Jan; 34(2):356-66. PubMed ID: 18432190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.